D.E. Shaw & Co’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
ACG
JMFC
D.E. Shaw & Co's DNA Position: Q2 2026 in Review
D.E. Shaw & Co increased its Ginkgo Bioworks (DNA) stake by 457% in Q2 2026, buying an estimated $1.04M and bringing the position to 151,356 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3443.
D.E. Shaw & Co first reported a position in DNA in Q3 2021 and has held it in 16 quarters since. The position peaked at $10.4M in Q3 2021. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.
- D.E. Shaw & Co held 151,356 shares of Ginkgo Bioworks worth $1.5M as of Q2 2026.
- D.E. Shaw & Co bought 124,187 Ginkgo Bioworks shares in Q2 2026, an estimated $1.04M.
- Ginkgo Bioworks made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3443 holding.
- D.E. Shaw & Co first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 16 quarters since.
- D.E. Shaw & Co's Ginkgo Bioworks position peaked at $10.4M in Q3 2021.
- 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.